Innovation to Impact Grants
This program has been designed to extend the CCSRI funding pipeline by filling the gap between Innovation and Impact Grants. This limited 2nd phase of funding is available to build upon significant findings from a successful Innovation Grant. Applicants are cautioned to carefully review the full description for details on the limited eligibility for this funding opportunity.
Scientific focus of the program and eligibility
Innovation to Impact Grants (i2I) are intended to support the further development of successful findings based on the goals originally explored through a CCSRI Innovation Grant. Therefore, only investigators with a funded Innovation Grant are eligible for this program.
Applicants are required to articulate specific achievements from the original Innovation Grant (i.e., significant new knowledge, publications, intellectual property, technology development, or relevant endpoints) and clearly describe and justify the progression to the new research proposed.
Investigators looking to explore unexpected outcomes or ideas not originally proposed in a funded Innovation Grant are encouraged to apply for a new Innovation Grant as the Innovation to Impact Grant program is designed to build upon successful outcomes from the objectives of the original Innovation grant. It is expected that the applicant pool to this program will be small due to the “high-risk” nature of Innovation Grants.
Please see the eligibility and requirements section prior to creating an application.
Fall program not being offered for February 15, 2017 abstract registration deadline. Please note the eligibility window will be extended as needed.
There is one competition tentatively planned, aligned with the Innovation Grants competitions.
Abstract registration due date: August 15
Full application due date: November 15
Results announcement: April
Anticipated start date: May 1
Abstract registration must be completed in order to submit a full application.
Application guides can be found on the EGrAMS documentation for applicants page. See FAQs.
There is one competition tentatively planned for funding in 2018. Grant budgets may be up to $150,000 per year with a maximum of 3 years of funding. It is expected that up to 10 grants will be awarded. Grants will be non-renewable.
Funding will be provided to support the direct costs of research, including supplies, salaries, and equipment associated with the proposed work. Equipment requests should not exceed $50,000 of the requested budget however an increase in this portion of the budget will be considered as an exceptional case if the i2I application involves the development of a technology or a platform that requires specific equipment to do so. Indirect costs are not eligible.
Peer review panels
Peer review committees will consist of scientific members with expertise relevant to the disciplines of research under review, as well as community representatives. External reviewers may also be recruited.
Review panel information can be found here.
A maximum of one i2I grant application resulting from a single Innovation Grant is allowed and must be submitted by the Principal Investigator or Co-Principal Investigator of the original Innovation Grant.
Registration is mandatory and will require applicant details (Principal Investigator(s)/Co-applicants/Additional Authors), scientific abstract, keywords and research tracking information as well as a statement of the achievements resulting from the Innovation Grant. There is no limit on the number of re-applications, however, applications must be made within two years of the end date of the original Innovation Grant.
When preparing the full application, the following will be required:
- as part of the public (non-scientific) summary, a cancer relevance statement describing the potential of this project to impact cancer control
- a scientific abstract
- a demonstration of significant achievements from the stated goals in the funded Innovation Grant and discussion of the clear progression of the work outlined in the i2I proposal (no more than 2 pages of single spaced text). Progress must be a direct result of the work completed within the Innovation Grant. Note that a publication resulting from the original Innovation grant is not required but it is necessary to include a clear description of specific outcomes and include relevant preliminary data in the i2I proposal.
- a detailed scientific proposal clearly stating the aims of the project including any previous work done in the area, study design, methods and analysis; a description of the expected impact that research results will have on reducing the burden of cancer; details of the investigator(s) including which member(s) of the research team will be responsible for which aspect of the project and a rationale for their inclusion in the project, as well as a description of the research environment where the work will take place (no more than 6 pages of single spaced text)
- a vision statement explicitly describing how the proposed work could move the field forward and accelerate progress in cancer research.
- data figures/tables/charts and their associated legends (no more than 5 pages)
- submission of the original Innovation Grant proposal, scientific abstract, and innovation statement.
- a budget justification related to the supplies, equipment and personnel associated with the research project. This must include the number of personnel required to complete the work and a description of their experience and/or education level and their commitment to the project. The budget request must be appropriate for the type of research proposed.
Specific guidelines for the online application are available.
The review criteria for the application will include the following:
- evidence of the successful testing of the hypotheses from the original Innovation Grant
- evidence of significant achievements made in the original Innovation Grant
- evidence of progression to show how the proposed work builds upon significant findings from the original Innovation Grant
- potential for impact
- feasibility and scientific merit
- qualifications and experience of the investigator(s)
- quality of the research environment
- potential for the advancement of the mission of the Canadian Cancer Society
- appropriateness of the term and amount of support requested
Multiple applications/multiple sources of funding
There must not be substantial overlap (i.e. more than 50%) with any pending application (including those at the abstract or Letter of Intent submission stage) to any other CCSRI program as of this competition due date. Duplicate applications will not be accepted. The onus is on the applicant to indicate the extent (or absence) of overlap. Grantees can accept funds from other sources, up to the CCSRI panel recommended amount in cases where the panel approved amount exceeds the annual funding limit.
Applicants are reminded to review the eligibility and requirements section for details on scientific and financial reporting, funder acknowledgement, Canadian Cancer Society policies on open access and tobacco related funding.
Last modified on: February 16, 2017